2025
SJR Q1
JCR Q2 · 2,6
2 matched articles
SCIE
Journal detail
Journal of Cardiovascular Translational Research
- Publisher
- Springer
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1937538719375395
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,802
- Quartile Q1
- H-Index 68
- Cites/doc 2,7
- Docs (3y) 400
- Cites (3y) 1.110
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,6
- 5Y JIF 2,8
- JCI 0,58
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q2
- Genetics Q2
- Genetics (clinical) Q2
- Molecular Medicine Q2
- Pharmaceutical Science Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Cardiac & Cardiovascular System | Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,802 | 2,6 | 2,8 | 0,58 | Q2 | 68 |
| 2024 | Q1 | Q2 | 0,844 | 2,5 | 2,9 | 0,61 | Q2 | 64 |
| 2023 | Q1 | Q2 | 0,768 | 2,4 | 2,9 | 0,64 | Q2 | 64 |
| 2022 | Q1 | Q2 | 0,853 | 3,4 | 3,5 | 0,63 | Q2 | 64 |
| 2021 | Q1 | Q3 | 0,764 | 3,2 | 3,5 | 0,69 | Q2 | 64 |
| 2020 | Q1 | Q2 | 1,028 | 4,1 | 3,7 | 0,93 | Q2 | 64 |
| 2019 | Q1 | Q2 | 1,143 | 3,3 | 2,7 | 0,9 | Q2 | 64 |
| 2018 | — | Q2 | — | 2,8 | 2,4 | 0,78 | Q2 | — |
| 2017 | Q1 | Q2 | 1,141 | 2,3 | 2,6 | 0,82 | Q2 | 64 |
| 2016 | Q1 | Q3 | 1,395 | 2,3 | 2,7 | — | — | 64 |
| 2015 | Q1 | Q2 | 1,553 | 3,2 | 3,1 | — | — | 64 |
| 2014 | Q1 | Q2 | 1,389 | 3 | 2,9 | — | — | 64 |
| 2013 | Q1 | Q2 | 1,418 | 2,7 | 2,4 | — | — | 64 |
| 2012 | Q1 | Q2 | 1,198 | 3,1 | 2,2 | — | — | 64 |
| 2011 | Q1 | Q2 | 0,982 | 2,6 | 2,2 | — | — | 64 |
| 2010 | Q2 | Q4 | 0,218 | 0,5 | 0,5 | — | — | 64 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 106/237 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 109/191 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 98/231 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 102/195 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 98/222 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 106/189 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 63/143 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 77/136 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 77/143 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 94/139 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 57/142 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 66/140 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 54/138 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 63/139 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 60/136 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 70/136 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 63/128 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 79/133 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 64/126 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 75/128 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 41/124 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 40/124 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 46/123 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 44/123 |
| 2013 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 50/125 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 51/124 |
| 2012 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 43/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 41/121 |
| 2011 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 45/117 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 45/112 |
| 2010 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 105/114 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 90/106 |